Here, following a chemistry-assisted, mechanism-based drug discovery approach, in combination with X-ray structure analysis, molecular modelling, cancer cell models and cell biological investigations, we have identified a potential anti-metastatic lead termed adhibin that develops its efficacy by targeting the motor function of the RhoGAP class-IX myosins. This evidence concerns the gene MYH14 and cancer.